Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Kodiak Sciences Inc.KOD · Entity 4388 | See Remarks | June 24, 2023 | June 27, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Kodiak Sciences Inc.
Report date June 24, 2023 · Filed June 27, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $7.24 · Expires 2033-06-23 | Direct | 207,500 |
Reported balance
After 2023-06-24 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2023-06-24 · Grant · Acquired 207,500 · Balance 207,500 F1: One-forty-eighth (1/48th) of the shares vest one month after July 1, 2023 (the "Vesting Commencement Date"); the balance of the shares vest in a series of forty-seven (47) successive equal monthly installments measured from the first month anniversary of the Vesting Commencement Date, subject to the Reporting Person's status as a Service Provider (as defined in the 2018 Equity Incentive Plan) on each vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: One-forty-eighth (1/48th) of the shares vest one month after July 1, 2023 (the "Vesting Commencement Date"); the balance of the shares vest in a series of forty-seven (47) successive equal monthly installments measured from the first month anniversary of the Vesting Commencement Date, subject to the Reporting Person's status as a Service Provider (as defined in the 2018 Equity Incentive Plan) on each vesting date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 24, 2023 Filed Jun 27, 2023 21:35 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | GrantStock Option (Right to Buy) · Derivative | 207,500 | $0.00 Strike: $7.24 | $0.00 |
DisclosureSEC source: 0001209191-23-039944 · doc4.xml · derivative · entry 1 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 207,500 Underlying: Common Stock · 207,500 shares Expires 2033-06-23 F1 · derivative.exercise_date: One-forty-eighth (1/48th) of the shares vest one month after July 1, 2023 (the "Vesting Commencement Date"); the balance of the shares vest in a series of forty-seven (47) successive equal monthly installments measured from the first month anniversary of the Vesting Commencement Date, subject to the Reporting Person's status as a Service Provider (as defined in the 2018 Equity Incentive Plan) on each vesting date. Read SEC document |
| June 16, 2023 Filed Jun 17, 2023 00:27 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | SaleCommon Stock | 2,258 | $9.23 | $20,841.34 |
DisclosureSEC source: 0001209191-23-038166 · doc4.xml · nonDerivative · entry 3 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 61,924 F3 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of the RSUs on June 15, 2023. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. The sale is intended to comply with the requirements of Rule 10b5-1(c)(1) under the Exchange Act and be interpreted to meet the requirements of Rule 10b5-1(c). Read SEC document |
| June 15, 2023 Filed Jun 17, 2023 00:27 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | Exercise / conversionRestricted Stock Units · Derivative | 1,875 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-038166 · doc4.xml · derivative · entry 5 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 3,750 Underlying: Common Stock · 1,875 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock. F5 · derivative.exercise_date: One-fourth (1/4th) of the RSUs vest on each of the first four anniversaries of June 15, 2021, subject to the Reporting Person's status as a Service Provider (as defined in the 2018 Equity Incentive Plan) on each vesting date. F5 · derivative.expiration_date: One-fourth (1/4th) of the RSUs vest on each of the first four anniversaries of June 15, 2021, subject to the Reporting Person's status as a Service Provider (as defined in the 2018 Equity Incentive Plan) on each vesting date. Read SEC document |
| June 15, 2023 Filed Jun 17, 2023 00:27 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | Exercise / conversionRestricted Stock Units · Derivative | 3,619 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-038166 · doc4.xml · derivative · entry 4 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 3,619 Underlying: Common Stock · 3,619 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock. F4 · derivative.exercise_date: One-fourth (1/4th) of the RSUs vest on each of the first four anniversaries of June 15, 2020, subject to the Reporting Person's status as a Service Provider (as defined in the 2018 Equity Incentive Plan) on each vesting date. F4 · derivative.expiration_date: One-fourth (1/4th) of the RSUs vest on each of the first four anniversaries of June 15, 2020, subject to the Reporting Person's status as a Service Provider (as defined in the 2018 Equity Incentive Plan) on each vesting date. Read SEC document |
| June 15, 2023 Filed Jun 17, 2023 00:27 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | Exercise / conversionCommon Stock | 5,494 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-038166 · doc4.xml · nonDerivative · entry 2 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 64,182 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock. Read SEC document |
| June 14, 2023 Filed Jun 17, 2023 00:27 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | SaleCommon Stock | 1,132 | $9.42 | $10,663.44 |
DisclosureSEC source: 0001209191-23-038166 · doc4.xml · nonDerivative · entry 1 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 58,688 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of the restricted stock units ("RSU") on June 11, 2023. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. The sale is intended to comply with the requirements of Rule 10b5-1(c)(1) under the Exchange Act and be interpreted to meet the requirements of Rule 10b5-1(c). Read SEC document |
| June 11, 2023 Filed Jun 13, 2023 21:33 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | Exercise / conversionRestricted Stock Units · Derivative | 2,900 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-036830 · doc4.xml · derivative · entry 2 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,900 Underlying: Common Stock · 2,900 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one (1) share of the Issuer's common stock. F2 · derivative.exercise_date: One-fourth (1/4th) of the RSUs vested on June 11, 2021, upon the achievement of certain performance criteria ("Performance Achievement Date"); thereafter, the RSUs will vest in three equal annual installments on each of the first, second, and third anniversaries of the Performance Achievement Date, subject, in each case, to the Reporting Person's status as a Service Provider (as defined in the 2018 Equity Incentive Plan) on each vesting date. F2 · derivative.expiration_date: One-fourth (1/4th) of the RSUs vested on June 11, 2021, upon the achievement of certain performance criteria ("Performance Achievement Date"); thereafter, the RSUs will vest in three equal annual installments on each of the first, second, and third anniversaries of the Performance Achievement Date, subject, in each case, to the Reporting Person's status as a Service Provider (as defined in the 2018 Equity Incentive Plan) on each vesting date. Read SEC document |
| June 11, 2023 Filed Jun 13, 2023 21:33 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | Exercise / conversionCommon Stock | 2,900 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-036830 · doc4.xml · nonDerivative · entry 1 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 59,820 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one (1) share of the Issuer's common stock. Read SEC document |
| July 06, 2022 Filed Jul 8, 2022 21:23 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | GrantStock Option (Right to Buy) · Derivative | 142,500 | $0.00 Strike: $8.15 | $0.00 |
DisclosureSEC source: 0001209191-22-041689 · doc4.xml · derivative · entry 1 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 142,500 Underlying: Common Stock · 142,500 shares Expires 2032-07-05 F1 · derivative.exercise_date: One-forty-eighth (1/48th) of the shares vest one month after July 1, 2022 (the "Vesting Commencement Date"); the balance of the shares vest in a series of forty-seven (47) successive equal monthly installments measured from the first month anniversary of the Vesting Commencement Date, subject to the Reporting Person's status as a Service Provider (as defined in the 2018 Equity Incentive Plan) on each vesting date. Read SEC document |
| June 17, 2022 Filed Jun 17, 2022 23:56 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | SaleCommon Stock | 2,282 | $7.02 | $16,019.64 |
DisclosureSEC source: 0001209191-22-038181 · doc4.xml · nonDerivative · entry 3 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,920 F3 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of the RSUs on June 15, 2022. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. The sale is intended to comply with the requirements of Rule 10b5-1(c)(1) under the Exchange Act and be interpreted to meet the requirements of Rule 10b5-1(c). Read SEC document |
| June 15, 2022 Filed Jun 17, 2022 23:56 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | Exercise / conversionRestricted Stock Units · Derivative | 1,875 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-038181 · doc4.xml · derivative · entry 5 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,625 Underlying: Common Stock · 1,875 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one (1) share of the Issuer's common stock. F5 · derivative.exercise_date: One-fourth (1/4th) of the RSUs vest on each of the first four anniversaries of June 15, 2021, subject to the Reporting Person's status as a Service Provider (as defined in the 2018 Equity Incentive Plan) on each vesting date. F5 · derivative.expiration_date: One-fourth (1/4th) of the RSUs vest on each of the first four anniversaries of June 15, 2021, subject to the Reporting Person's status as a Service Provider (as defined in the 2018 Equity Incentive Plan) on each vesting date. Read SEC document |
| June 15, 2022 Filed Jun 17, 2022 23:56 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | Exercise / conversionRestricted Stock Units · Derivative | 3,619 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-038181 · doc4.xml · derivative · entry 4 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,238 Underlying: Common Stock · 3,619 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one (1) share of the Issuer's common stock. F4 · derivative.exercise_date: One-fourth (1/4th) of the RSUs vest on each of the first four anniversaries of June 15, 2020, subject to the Reporting Person's status as a Service Provider (as defined in the 2018 Equity Incentive Plan) on each vesting date. F4 · derivative.expiration_date: One-fourth (1/4th) of the RSUs vest on each of the first four anniversaries of June 15, 2020, subject to the Reporting Person's status as a Service Provider (as defined in the 2018 Equity Incentive Plan) on each vesting date. Read SEC document |
| June 15, 2022 Filed Jun 17, 2022 23:56 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | SaleCommon Stock | 1,205 | $7.21 | $8,688.05 |
DisclosureSEC source: 0001209191-22-038181 · doc4.xml · nonDerivative · entry 2 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,202 F2 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of the RSUs on June 11, 2022. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. The sale is intended to comply with the requirements of Rule 10b5-1(c)(1) under the Exchange Act and be interpreted to meet the requirements of Rule 10b5-1(c). Read SEC document |
| June 15, 2022 Filed Jun 17, 2022 23:56 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | Exercise / conversionCommon Stock | 5,494 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-038181 · doc4.xml · nonDerivative · entry 1 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,407 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one (1) share of the Issuer's common stock. Read SEC document |
| June 11, 2022 Filed Jun 15, 2022 00:32 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | Exercise / conversionRestricted Stock Units · Derivative | 2,900 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-036834 · doc4.xml · derivative · entry 2 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,800 Underlying: Common Stock · 2,900 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one (1) share of the Issuer's common stock. F3 · derivative.exercise_date: One-fourth (1/4th) of the RSUs vested on June 11, 2021, upon the achievement of certain performance criteria ("Performance Achievement Date"); thereafter, the RSUs will vest in three equal annual installments on each of the first, second, and third anniversaries of the Performance Achievement Date, subject, in each case, to the Reporting Person's status as a Service Provider (as defined in the 2018 Equity Incentive Plan) on each vesting date. F3 · derivative.expiration_date: One-fourth (1/4th) of the RSUs vested on June 11, 2021, upon the achievement of certain performance criteria ("Performance Achievement Date"); thereafter, the RSUs will vest in three equal annual installments on each of the first, second, and third anniversaries of the Performance Achievement Date, subject, in each case, to the Reporting Person's status as a Service Provider (as defined in the 2018 Equity Incentive Plan) on each vesting date. Read SEC document |
| June 11, 2022 Filed Jun 15, 2022 00:32 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | Exercise / conversionCommon Stock | 2,900 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-036834 · doc4.xml · nonDerivative · entry 1 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,913 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one (1) share of the Issuer's common stock. F2 · balance_after: Includes (i) 73 shares acquired under the 2018 Employee Stock Purchase Plan ("ESPP") on November 30, 2021 and (ii) 399 shares acquired under the ESPP on May 31, 2022. Read SEC document |
| February 16, 2022 Filed Feb 18, 2022 22:14 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | GrantStock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $131.44 | $0.00 |
DisclosureSEC source: 0001209191-22-011374 · doc4.xml · derivative · entry 1 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2031-02-20 F1 · derivative.exercise_date: On February 21, 2021, the Reporting Person was awarded a performance-based option. 1/4th of the shares subject to the option vested on February 16, 2022 upon the achievement of certain performance criteria (the "Performance Criteria Achievement Date"); thereafter, the shares subject to the option will vest in thirty-six (36) successive equal monthly installments measured from the Performance Criteria Achievement Date, subject, in each case, to the Reporting Person's status as a Service Provider (as defined in the 2018 Equity Incentive Plan) on each vesting date. Read SEC document |
| January 20, 2022 Filed Jan 24, 2022 22:17 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | Exercise / conversionStock Option (Right to Buy) · Derivative | 6,950 | $0.00 Strike: $10.29 | $0.00 |
DisclosureSEC source: 0001209191-22-004636 · doc4.xml · derivative · entry 7 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 218,538 Underlying: Common Stock · 6,950 shares Expires 2028-08-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: Twenty-five percent of the shares subject to the option vested on September 1, 2019, and 1/48th of the shares subject to the option vest on the same day of each month thereafter. Read SEC document |
| January 20, 2022 Filed Jan 24, 2022 22:17 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | SaleCommon Stock | 198 | $66.91 | $13,249.13 |
DisclosureSEC source: 0001209191-22-004636 · doc4.xml · nonDerivative · entry 6 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,541 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan. F6 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $66.91 to $66.99, inclusive. Read SEC document |
| January 20, 2022 Filed Jan 24, 2022 22:17 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | SaleCommon Stock | 533 | $66.28 | $35,328.89 |
DisclosureSEC source: 0001209191-22-004636 · doc4.xml · nonDerivative · entry 5 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,739 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan. F5 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $65.85 to $66.41, inclusive. Read SEC document |
| January 20, 2022 Filed Jan 24, 2022 22:17 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | SaleCommon Stock | 2,995 | $65.00 | $194,688.78 |
DisclosureSEC source: 0001209191-22-004636 · doc4.xml · nonDerivative · entry 4 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,272 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan. F4 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $64.395 to $65.33, inclusive. Read SEC document |
| January 20, 2022 Filed Jan 24, 2022 22:17 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | SaleCommon Stock | 2,416 | $63.55 | $153,546.71 |
DisclosureSEC source: 0001209191-22-004636 · doc4.xml · nonDerivative · entry 3 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,267 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan. F3 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $63.135 to $64.11, inclusive. Read SEC document |
| January 20, 2022 Filed Jan 24, 2022 22:17 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | SaleCommon Stock | 808 | $62.72 | $50,680.35 |
DisclosureSEC source: 0001209191-22-004636 · doc4.xml · nonDerivative · entry 2 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,683 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan. F2 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $62.02 to $62.98, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in these footnotes. Read SEC document |
| January 20, 2022 Filed Jan 24, 2022 22:17 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | Exercise / conversionCommon Stock | 6,950 | $10.29 | $71,515.50 |
DisclosureSEC source: 0001209191-22-004636 · doc4.xml · nonDerivative · entry 1 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,491 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 20, 2021 Filed Dec 22, 2021 21:35 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | Exercise / conversionStock Option (Right to Buy) · Derivative | 6,950 | $0.00 Strike: $10.29 | $0.00 |
DisclosureSEC source: 0001209191-21-070934 · doc4.xml · derivative · entry 5 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 225,488 Underlying: Common Stock · 6,950 shares Expires 2028-08-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Twenty-five percent of the shares subject to the option vested on September 1, 2019, and 1/48th of the shares subject to the option vest on the same day of each month thereafter. Read SEC document |
| December 20, 2021 Filed Dec 22, 2021 21:35 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | SaleCommon Stock | 1,709 | $88.51 | $151,269.57 |
DisclosureSEC source: 0001209191-21-070934 · doc4.xml · nonDerivative · entry 4 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,541 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan. F4 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $88.13 to $89.01, inclusive. Read SEC document |
| December 20, 2021 Filed Dec 22, 2021 21:35 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | SaleCommon Stock | 3,709 | $87.60 | $324,890.60 |
DisclosureSEC source: 0001209191-21-070934 · doc4.xml · nonDerivative · entry 3 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,250 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan. F3 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $87.06 to $88.035, inclusive. Read SEC document |
| December 20, 2021 Filed Dec 22, 2021 21:35 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | SaleCommon Stock | 1,532 | $86.60 | $132,670.59 |
DisclosureSEC source: 0001209191-21-070934 · doc4.xml · nonDerivative · entry 2 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,959 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan. F2 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $86.085 to $87.025, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in these footnotes. Read SEC document |
| December 20, 2021 Filed Dec 22, 2021 21:35 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | Exercise / conversionCommon Stock | 6,950 | $10.29 | $71,515.50 |
DisclosureSEC source: 0001209191-21-070934 · doc4.xml · nonDerivative · entry 1 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,491 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 22, 2021 Filed Nov 24, 2021 21:55 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | Exercise / conversionStock Option (Right to Buy) · Derivative | 6,950 | $0.00 Strike: $10.29 | $0.00 |
DisclosureSEC source: 0001209191-21-066813 · doc4.xml · derivative · entry 7 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 232,438 Underlying: Common Stock · 6,950 shares Expires 2028-08-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: Twenty-five percent of the shares subject to the option vested on September 1, 2019, and 1/48th of the shares subject to the option vest on the same day of each month thereafter. Read SEC document |
| November 22, 2021 Filed Nov 24, 2021 21:55 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | SaleCommon Stock | 106 | $101.21 | $10,728.26 |
DisclosureSEC source: 0001209191-21-066813 · doc4.xml · nonDerivative · entry 6 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,541 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan. F5 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $101.17 to $101.27, inclusive. Read SEC document |
| November 22, 2021 Filed Nov 24, 2021 21:55 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | SaleCommon Stock | 1,071 | $100.44 | $107,571.24 |
DisclosureSEC source: 0001209191-21-066813 · doc4.xml · nonDerivative · entry 5 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,647 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan. F4 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $100.155 to $101.095, inclusive. Read SEC document |
| November 22, 2021 Filed Nov 24, 2021 21:55 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | SaleCommon Stock | 1,881 | $99.57 | $187,291.17 |
DisclosureSEC source: 0001209191-21-066813 · doc4.xml · nonDerivative · entry 4 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,718 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan. F3 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $99.12 to $100.08, inclusive. Read SEC document |
| November 22, 2021 Filed Nov 24, 2021 21:55 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | SaleCommon Stock | 3,701 | $98.63 | $365,029.63 |
DisclosureSEC source: 0001209191-21-066813 · doc4.xml · nonDerivative · entry 3 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,599 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan. F2 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $98.06 to $99.04, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in these footnotes. Read SEC document |
| November 22, 2021 Filed Nov 24, 2021 21:55 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | SaleCommon Stock | 191 | $96.82 | $18,492.62 |
DisclosureSEC source: 0001209191-21-066813 · doc4.xml · nonDerivative · entry 2 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,300 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan. Read SEC document |
| November 22, 2021 Filed Nov 24, 2021 21:55 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | Exercise / conversionCommon Stock | 6,950 | $10.29 | $71,515.50 |
DisclosureSEC source: 0001209191-21-066813 · doc4.xml · nonDerivative · entry 1 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,491 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 20, 2021 Filed Oct 22, 2021 20:52 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | Exercise / conversionStock Option (Right to Buy) · Derivative | 6,950 | $0.00 Strike: $10.29 | $0.00 |
DisclosureSEC source: 0001209191-21-061375 · doc4.xml · derivative · entry 4 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 239,388 Underlying: Common Stock · 6,950 shares Expires 2028-08-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Twenty-five percent of the shares subject to the option vested on September 1, 2019, and 1/48th of the shares subject to the option vest on the same day of each month thereafter. Read SEC document |
| October 20, 2021 Filed Oct 22, 2021 20:52 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | SaleCommon Stock | 1,252 | $112.73 | $141,143.59 |
DisclosureSEC source: 0001209191-21-061375 · doc4.xml · nonDerivative · entry 3 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,541 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan. F3 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $112.23 to $113.16, inclusive. Read SEC document |
| October 20, 2021 Filed Oct 22, 2021 20:52 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | SaleCommon Stock | 5,698 | $111.56 | $635,680.85 |
DisclosureSEC source: 0001209191-21-061375 · doc4.xml · nonDerivative · entry 2 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,793 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan. F2 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $111.16 to $112.04, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in these footnotes. Read SEC document |
| October 20, 2021 Filed Oct 22, 2021 20:52 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | Exercise / conversionCommon Stock | 6,950 | $10.29 | $71,515.50 |
DisclosureSEC source: 0001209191-21-061375 · doc4.xml · nonDerivative · entry 1 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,491 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 20, 2021 Filed Sep 22, 2021 21:02 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | Exercise / conversionStock Option (Right to Buy) · Derivative | 6,950 | $0.00 Strike: $10.29 | $0.00 |
DisclosureSEC source: 0001209191-21-057278 · doc4.xml · derivative · entry 5 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 246,338 Underlying: Common Stock · 6,950 shares Expires 2028-08-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Twenty-five percent of the shares subject to the option vested on September 1, 2019, and 1/48th of the shares subject to the option vest on the same day of each month thereafter. Read SEC document |
| September 20, 2021 Filed Sep 22, 2021 21:02 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | SaleCommon Stock | 349 | $101.31 | $35,356.95 |
DisclosureSEC source: 0001209191-21-057278 · doc4.xml · nonDerivative · entry 4 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,541 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan. F4 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $101.175 to $101.94, inclusive. Read SEC document |
| September 20, 2021 Filed Sep 22, 2021 21:02 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | SaleCommon Stock | 503 | $100.52 | $50,563.82 |
DisclosureSEC source: 0001209191-21-057278 · doc4.xml · nonDerivative · entry 3 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,890 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan. F3 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $100.14 to $100.96, inclusive. Read SEC document |
| September 20, 2021 Filed Sep 22, 2021 21:02 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | SaleCommon Stock | 6,098 | $99.74 | $608,243.18 |
DisclosureSEC source: 0001209191-21-057278 · doc4.xml · nonDerivative · entry 2 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,393 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan. F2 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $99.095 to $100.08, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in these footnotes. Read SEC document |
| September 20, 2021 Filed Sep 22, 2021 21:02 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | Exercise / conversionCommon Stock | 6,950 | $10.29 | $71,515.50 |
DisclosureSEC source: 0001209191-21-057278 · doc4.xml · nonDerivative · entry 1 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,491 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 20, 2021 Filed Aug 24, 2021 20:59 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | Exercise / conversionStock Option (Right to Buy) · Derivative | 5,258 | $0.00 Strike: $10.29 | $0.00 |
DisclosureSEC source: 0001209191-21-053158 · doc4.xml · derivative · entry 8 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 253,288 Underlying: Common Stock · 5,258 shares Expires 2028-08-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: Twenty-five percent of the shares subject to the option vested on September 1, 2019, and 1/48th of the shares subject to the option vest on the same day of each month thereafter. Read SEC document |
| August 20, 2021 Filed Aug 24, 2021 20:59 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | SaleCommon Stock | 23 | $93.04 | $2,139.92 |
DisclosureSEC source: 0001209191-21-053158 · doc4.xml · nonDerivative · entry 7 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,541 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan. Read SEC document |
| August 20, 2021 Filed Aug 24, 2021 20:59 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | SaleCommon Stock | 2,278 | $92.52 | $210,764.66 |
DisclosureSEC source: 0001209191-21-053158 · doc4.xml · nonDerivative · entry 6 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,564 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan. F6 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $92.02 to $92.995, inclusive. Read SEC document |
| August 20, 2021 Filed Aug 24, 2021 20:59 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | SaleCommon Stock | 3,193 | $91.60 | $292,463.47 |
DisclosureSEC source: 0001209191-21-053158 · doc4.xml · nonDerivative · entry 5 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,842 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan. F5 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $91.10 to $91.995, inclusive. Read SEC document |
| August 20, 2021 Filed Aug 24, 2021 20:59 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | SaleCommon Stock | 542 | $90.64 | $49,128.24 |
DisclosureSEC source: 0001209191-21-053158 · doc4.xml · nonDerivative · entry 4 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,035 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan. F4 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $89.945 to $90.94, inclusive. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.